Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study

Post time 2024-5-27 13:52:58

journal：Frontiers in Pharmacology

Authors：Xue Zhao; Hongzhong Liu; Wei Tian; Ligang Fang; Mengyang Yu; Xiaofei Wu; Aijing Liu; Ruijie Wan; Li Li; Jinghui Luo; Yuqiong Li; Bo Liu; Yu He; Xiaowen Chen; Yuan Li; Donghong Xu; Hongyun Wang; Xiaohong Han

Published date：--

DOI：10.3389/fphar.2023.1227470

PDF link：https://www.frontiersin.org/arti ... r.2023.1227470/full

Article link：http://dx.doi.org/10.3389/fphar.2023.1227470

Article Source：Frontiers Media SA。

Remark：

Post time 2024-5-27 13:52:59

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study